Board of Advisors

Our Board of Advisors, all industry leaders, have made a powerful statement by supporting Life Science Cares and our goal to end poverty in our community. Annually, our Advisors make a personal financial contribution to cover LSC’s administrative costs, allowing us to channel money raised from our event fundraisers, Corporate Membership Program, and from individuals to our partner organizations.

Our Board of Advisor members also choose to volunteer with their companies and recruit their colleagues to join in this collective effort.

BAY AREA BOARD OF ADVISORS

ABCDEFGHIJKLMNOPQRSTUVWXYZ
Heather Behanna

Heather Behanna

Principal

SR One

Oren  Beske

Oren Beske

Amalgamator, Business and Biology

Atum Bio

Jane  Chung

Jane Chung

Chief Commercial Officer (CCO)

Sutro Biopharma

Kimberly Cline

Kimberly Cline

Senior Vice President Commercialization Strategy and Business Development

Two Labs

Bernard Coulie

Bernard Coulie

President and Chief Executive Officer

Pliant Therapeutics

Mardi Dier

Mardi Dier

Chief Financial Officer

Ultragenyx

Nick Englezos

Nick Englezos

Executive Vice President

The Lynx Group

Adam Gridley

Adam Gridley

Chief Executive Officer

Allay Therapeutics

Dennis He

Dennis He

Director, Life Science and Healthcare

Allison Huckstepp

Allison Huckstepp

Managing Director, Life Sciences

T3 Advisors

Dennis Lanfear

Dennis Lanfear

President and Chief Executive Officer

Coherus

Doug Love

Doug Love

President and CEO

Annexon Biosciences

Oleg Nodelman

Oleg Nodelman

Founder and Managing Director

EcoR1 Capital

Omondi Nyong'o

Omondi Nyong'o

Medical Director of Philantropy

Sutter Health

Chris  Peetz

Chris Peetz

Chief Executive Officer

Mirum Pharmaceuticals

Mary Stutts

Mary Stutts

Chief Global Inclusion & Health Equity Officer

Real Chemistry

Senthil Sundharam

Senthil Sundharam

Chief Executive Officer

Terns Pharmaceuticals

Josh Thornton

Josh Thornton

Partner

Centerview Partners

Barbara Troupin

Barbara Troupin

Chief Medical Officer

Scott Turner

Scott Turner

Senior Vice President/ Head of Research

Pliant Therapeutics